Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data

dc.contributor.authorWang, Limei
dc.contributor.authorLi, Jin
dc.contributor.authorLiu, Enze
dc.contributor.authorKinnebrew, Garrett
dc.contributor.authorZhang, Xiaoli
dc.contributor.authorStover, Daniel
dc.contributor.authorHuo, Yang
dc.contributor.authorZeng, Zhi
dc.contributor.authorJiang, Wanli
dc.contributor.authorCheng, Lijun
dc.contributor.authorFeng, Weixing
dc.contributor.authorLi, Lang
dc.contributor.departmentBioHealth Informatics, School of Informatics and Computingen_US
dc.date.accessioned2020-01-09T15:07:14Z
dc.date.available2020-01-09T15:07:14Z
dc.date.issued2019-09-25
dc.description.abstractAlternatively-activated pathways have been observed in biological experiments in cancer studies, but the concept had not been fully explored in computational cancer system biology. Therefore, an alternatively-activated pathway identification method was proposed and applied to primary breast cancer and breast cancer liver metastasis research using microarray data. Interestingly, the results show that cytokine-cytokine receptor interaction and calcium signaling were significantly enriched under both conditions. TGF beta signaling was found to be the hub in network topology analysis. In total, three types of alternatively-activated pathways were recognized. In the cytokine-cytokine receptor interaction pathway, four active alteration patterns in gene pairs were noticed. Thirteen cytokine-cytokine receptor pairs with inverse activity changes of both genes were verified by the literature. The second type was that some sub-pathways were active under only one condition. For the third type, nodes were significantly active in both conditions, but with different active genes. In the calcium signaling and TGF beta signaling pathways, node E2F5 and E2F4 were significantly active in primary breast cancer and metastasis, respectively. Overall, our study demonstrated the first time using microarray data to identify alternatively-activated pathways in breast cancer liver metastasis. The results showed that the proposed method was valid and effective, which could be helpful for future research for understanding the mechanism of breast cancer metastasis.en_US
dc.identifier.citationWang, L., Li, J., Liu, E., Kinnebrew, G., Zhang, X., Stover, D., … Li, L. (2019). Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data. Genes, 10(10), 753. doi:10.3390/genes10100753en_US
dc.identifier.urihttps://hdl.handle.net/1805/21801
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/genes10100753en_US
dc.relation.journalGenesen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectAlternatively-activated pathwayen_US
dc.subjectBreast canceren_US
dc.subjectLiver metastasisen_US
dc.subjectMicroarrayen_US
dc.subjectGene active statusen_US
dc.titleIdentification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Dataen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
genes-10-00753.pdf
Size:
1.22 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: